Prespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...

Olawaiye noted that the combination is a "well-tolerated regimen and we believe it should be a new standard for ...

Ovarian cancer isn't silent - learn the early warning signs. Persistent bloating, pelvic pain, urinary symptoms revealed.

Brian Slomovitz, MD, of Mount Sinai Medical Center, compares relacorilant plus nab-paclitaxel with existing treatments for platinum-resistant ovarian cancer and highlights the ROSELLA trial’s global ...

Corcept Therapeutics’ relacorilant, a selective glucocorticoid receptor antagonist (SGRA), is emerging as a novel therapeutic ...

One woman's story of literal strength illustrates how ovarian cancer symptoms can be missed—and the lighthearted recovery ...

It’s often diagnosed at a late stage. But with a new blood test, scientists believe that survival rate could soar.

Researchers compare relacorilant plus nab-paclitaxel with nab-paclitaxel monotherapy in patients with platinum-resistant ...

Around one in 10 women will develop ovarian cysts at some point during their lives, and while the prospect of a cyst growing ...

Ovarian cancer can affect fertility, but with timely intervention and advanced preservation methods, women of childbearing age can still plan for biological motherhood after treatment., Health News - ...